18
Participants
Start Date
October 31, 2007
Primary Completion Date
March 31, 2009
Study Completion Date
March 31, 2009
Sorafenib
Sorafenib 200mg po daily
Bevacizumab
"Bevacizumab 5mg/kg every other week~1 Cycle = 4 weeks"
Imaging
Imaging every third cycle
Ireland Cancer Center - University Hospitals of Cleveland, Cleveland
Indiana University Simon Cancer Center, Indianapolis
Quality Cancer Center (MCGOP), Indianapolis
Northern Indiana Cancer Research Consortium, South Bend
Fort Wayne Oncology & Hematology, Inc, Fort Wayne
Medical Consultants, P.C., Muncie
Oncology Hematology Associates of SW Indiana, Evansville
Arnett Cancer Care, Lafayette
Horizon Oncology Center, Lafayette
Medical & Surgical Specialists, LLC, Galesburg
Lead Sponsor
Collaborators (3)
Genentech, Inc.
INDUSTRY
Bayer
INDUSTRY
Amgen
INDUSTRY
Hoosier Cancer Research Network
OTHER